US-based healthcare company Merck invested $35m in the Merck Lumira Biosciences Fund yesterday, taking it to $43m raised. The fund is targeting a $50m final closing. The fund was set up by a Merck subsidiary in collaboration with venture firm Lumira Capital, and fund of funds Teralys Capital, which is also investing in the fund, and other…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
